Skip to main content
Erschienen in: Cancer Causes & Control 5/2014

01.05.2014 | Original paper

Regional variations in German mesothelioma mortality rates: 2000–2010

verfasst von: Sara J. Schonfeld, Valerie McCormack, Mark J. Rutherford, Joachim Schüz

Erschienen in: Cancer Causes & Control | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Germany has one of the highest age-adjusted mesothelioma mortality rates worldwide. As mesothelioma occurs ≥30 years after asbestos exposure, contemporary rates likely reflect exposures in the 1960–1970s. During this period, political division between West and East Germany led to differences regarding the import and consumption of asbestos. It is unclear whether mesothelioma rates also differ between these formerly separate countries which are now served by similar health and mortality reporting systems, thereby facilitating regional comparisons.

Methods

We examined regional, temporal, and sex variations in mesothelioma mortality rates in Germany in 2000–2010, collapsing the federal states into West Germany, East Germany, and Berlin. We calculated truncated (≥40 years) age-standardized mesothelioma mortality rates (ASRs40+) per 100,000 person-years, estimated sex-stratified mortality rate ratios (MRRs) (95 % confidence intervals (CIs)), adjusted for age and calendar year from Poisson models, and fitted age–period–cohort models.

Results

There were 12,854 mesothelioma deaths at ages ≥ 40 years in Germany during 2000–2010. ASRs40+ were higher in West (males 4.4; females 0.8) than East (males 1.7; females 0.6) Germany. MRRs for West versus East Germany were 2.68 (95 % CI 2.48–2.88) among males and 1.42 (95 % CI 1.27–1.59) among females. In both regions, mortality rates increased for birth cohorts until the mid 1940s and subsequently declined. The country’s peak mesothelioma burden is predicted to occur by 2020.

Conclusions

Geographical differences in mesothelioma mortality rates are consistent with heterogeneous historical asbestos exposures. Differences may exist for other asbestos-related cancers and should be investigated in analytic studies with individual asbestos exposure information.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Boffetta P, Stayner L (2006) Pleural and peritoneal neosplasms. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Oxford, pp 659–673 Boffetta P, Stayner L (2006) Pleural and peritoneal neosplasms. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, Oxford, pp 659–673
2.
Zurück zum Zitat Peto J, Hodgson JT, Matthews FE, Jones JR (1995) Continuing increase in mesothelioma mortality in Britain. Lancet 345(8949):535–539PubMedCrossRef Peto J, Hodgson JT, Matthews FE, Jones JR (1995) Continuing increase in mesothelioma mortality in Britain. Lancet 345(8949):535–539PubMedCrossRef
3.
Zurück zum Zitat Price B, Ware A (2004) Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003. Am J Epidemiol 159(2):107–112PubMedCrossRef Price B, Ware A (2004) Mesothelioma trends in the United States: an update based on surveillance, epidemiology, and end results program data for 1973 through 2003. Am J Epidemiol 159(2):107–112PubMedCrossRef
4.
Zurück zum Zitat Bianchi C, Bianchi T (2007) Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 45(3):379–387PubMedCrossRef Bianchi C, Bianchi T (2007) Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 45(3):379–387PubMedCrossRef
5.
Zurück zum Zitat Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T (2011) Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 89(10):716–724CPubMedCentralPubMedCrossRef Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, Sorahan T (2011) Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ 89(10):716–724CPubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Jemal A, Grauman D, Devesa S (2000) Recent geographic patterns of lung cancer and mesothelioma mortality rates in 49 shipyard counties in the United States, 1970–1994. Am J Ind Med 37(5):512–521PubMedCrossRef Jemal A, Grauman D, Devesa S (2000) Recent geographic patterns of lung cancer and mesothelioma mortality rates in 49 shipyard counties in the United States, 1970–1994. Am J Ind Med 37(5):512–521PubMedCrossRef
7.
Zurück zum Zitat Okello C, Treasure T, Nicholson AG, Peto J, Moller H (2009) Certified causes of death in patients with mesothelioma in South East England. BMC Cancer 9:28PubMedCentralPubMedCrossRef Okello C, Treasure T, Nicholson AG, Peto J, Moller H (2009) Certified causes of death in patients with mesothelioma in South East England. BMC Cancer 9:28PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Doll R, Cook P (1967) Summarizing indices for comparison of cancer incidence data. Int J Cancer 2(3):269–279PubMedCrossRef Doll R, Cook P (1967) Summarizing indices for comparison of cancer incidence data. Int J Cancer 2(3):269–279PubMedCrossRef
9.
Zurück zum Zitat Rutherford MJ, Lambert PC, Thompson JR (2010) Age-period-cohort modelling. Stata J 10:602–627 Rutherford MJ, Lambert PC, Thompson JR (2010) Age-period-cohort modelling. Stata J 10:602–627
10.
Zurück zum Zitat Pisati M (2004) Simple thematic mapping. Stata J 4:361–378 Pisati M (2004) Simple thematic mapping. Stata J 4:361–378
11.
Zurück zum Zitat Rutherford MJ, Thompson JR, Lambert PC (2012) Projecting cancer incidence using age-period-cohort models incorporating restricted cubic splines. Int J Biostat 8(1):33PubMedCrossRef Rutherford MJ, Thompson JR, Lambert PC (2012) Projecting cancer incidence using age-period-cohort models incorporating restricted cubic splines. Int J Biostat 8(1):33PubMedCrossRef
12.
Zurück zum Zitat Goldberg S, Rey G, Luce D et al (2010) Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates. Occup Environ Med 67(6):417–421PubMedCrossRef Goldberg S, Rey G, Luce D et al (2010) Possible effect of environmental exposure to asbestos on geographical variation in mesothelioma rates. Occup Environ Med 67(6):417–421PubMedCrossRef
13.
Zurück zum Zitat Hagemeyer O, Otten H, Kraus T (2006) Asbestos consumption, asbestos exposure and asbestos-related occupational diseases in Germany. Int Arch Occup Environ Health 79(8):613–620PubMedCrossRef Hagemeyer O, Otten H, Kraus T (2006) Asbestos consumption, asbestos exposure and asbestos-related occupational diseases in Germany. Int Arch Occup Environ Health 79(8):613–620PubMedCrossRef
14.
Zurück zum Zitat Virta RL (2006) Worldwide asbestos supply and consumption trends from 1900 through 2003 Virta RL (2006) Worldwide asbestos supply and consumption trends from 1900 through 2003
15.
Zurück zum Zitat Pott F (1994) Asbestos use and carcinogenicity in Germany and a comparison with animal studies. Ann Occup Hyg 38(4):589–600, 420 Pott F (1994) Asbestos use and carcinogenicity in Germany and a comparison with animal studies. Ann Occup Hyg 38(4):589–600, 420
16.
Zurück zum Zitat Sturm W, Menze B, Krause J, Thriene B (1994) Use of asbestos, health risks and induced occupational diseases in the former East Germany. Toxicol Lett 72(1–3):317–324PubMedCrossRef Sturm W, Menze B, Krause J, Thriene B (1994) Use of asbestos, health risks and induced occupational diseases in the former East Germany. Toxicol Lett 72(1–3):317–324PubMedCrossRef
17.
Zurück zum Zitat Sturm W, Menze B, Krause J, Thriene B (1995) Asbestos-related diseases and asbestos types used in the former GDR. Exp Toxicol Pathol 47(2–3):173–178PubMedCrossRef Sturm W, Menze B, Krause J, Thriene B (1995) Asbestos-related diseases and asbestos types used in the former GDR. Exp Toxicol Pathol 47(2–3):173–178PubMedCrossRef
18.
Zurück zum Zitat Arendt M, Blome H, Bonk L et al (2013) Faserjahre. BK-report 1/2013. Deutsche Gesetzliche Unfallversicherung (DGUV), Berlin 2013 Arendt M, Blome H, Bonk L et al (2013) Faserjahre. BK-report 1/2013. Deutsche Gesetzliche Unfallversicherung (DGUV), Berlin 2013
19.
20.
Zurück zum Zitat IARC (2012) A review of human carcinogens: arsenic, metals, fibres, and dusts. IARC monographs on the evaluation of carcinogenic risks to humans, vol 100 C IARC (2012) A review of human carcinogens: arsenic, metals, fibres, and dusts. IARC monographs on the evaluation of carcinogenic risks to humans, vol 100 C
21.
Zurück zum Zitat Montanaro F, Bray F, Gennaro V et al (2003) Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 14(8):791–803PubMedCrossRef Montanaro F, Bray F, Gennaro V et al (2003) Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 14(8):791–803PubMedCrossRef
22.
Zurück zum Zitat Darnton A, Hodgson J, Benson P, Coggon D (2012) Mortality from asbestosis and mesothelioma in Britain by birth cohort. Occup Med (Lond) 62(7):549–552CrossRef Darnton A, Hodgson J, Benson P, Coggon D (2012) Mortality from asbestosis and mesothelioma in Britain by birth cohort. Occup Med (Lond) 62(7):549–552CrossRef
23.
Zurück zum Zitat Burdorf A, Jarvholm B, Englund A (2005) Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands. Int J Cancer 113(2):298–301PubMedCrossRef Burdorf A, Jarvholm B, Englund A (2005) Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands. Int J Cancer 113(2):298–301PubMedCrossRef
24.
Zurück zum Zitat Fuchs-Schundeln N, Schundeln M (2009) Who stays, who goes, who returns? East-West migration within Germany since reunification. Econ Transit 17(4):703–738CrossRef Fuchs-Schundeln N, Schundeln M (2009) Who stays, who goes, who returns? East-West migration within Germany since reunification. Econ Transit 17(4):703–738CrossRef
26.
Zurück zum Zitat Schuz J, Schonfeld SJ, Kromhout H et al (2013) A retrospective cohort study of cancer mortality in employees of a Russian chrysotile asbestos mine and mills: study rationale and key features. Cancer Epidemiol 37(4):440–445PubMedCrossRef Schuz J, Schonfeld SJ, Kromhout H et al (2013) A retrospective cohort study of cancer mortality in employees of a Russian chrysotile asbestos mine and mills: study rationale and key features. Cancer Epidemiol 37(4):440–445PubMedCrossRef
27.
Zurück zum Zitat Pesch B, Taeger D, Johnen G et al (2010) Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos. Int J Hyg Environ Health 213(1):44–51PubMedCrossRef Pesch B, Taeger D, Johnen G et al (2010) Cancer mortality in a surveillance cohort of German males formerly exposed to asbestos. Int J Hyg Environ Health 213(1):44–51PubMedCrossRef
28.
Zurück zum Zitat van Kampen V, Merget R, Butz M, Taeger D, Bruning T (2008) Trends in suspected and recognized occupational respiratory diseases in Germany between 1970 and 2005. Am J Ind Med 51(7):492–502PubMedCrossRef van Kampen V, Merget R, Butz M, Taeger D, Bruning T (2008) Trends in suspected and recognized occupational respiratory diseases in Germany between 1970 and 2005. Am J Ind Med 51(7):492–502PubMedCrossRef
Metadaten
Titel
Regional variations in German mesothelioma mortality rates: 2000–2010
verfasst von
Sara J. Schonfeld
Valerie McCormack
Mark J. Rutherford
Joachim Schüz
Publikationsdatum
01.05.2014
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 5/2014
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0368-4

Weitere Artikel der Ausgabe 5/2014

Cancer Causes & Control 5/2014 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.